Early treatment effect and prognosis measurement of bone metastasis in prostate cancer patients by using whole-body diffusion-weighted imaging.

Early treatment effect and prognosis measurement of bone metastasis in prostate cancer patients by using whole-body diffusion-weighted imaging. - Bone metastasis evaluation in prostate cancer patients by using whole-body diffusion-weighted imaging.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000035857

Enrollment

Registered

2019-02-12

Start date

2019-02-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Prostate cancer patients before or under hormonal therapy or chemotherapy who agreed written informed consent for participating in this study.

Exclusion criteria

Exclusion criteria: 1) Under 20 years old 2) The person who has internal implantation material to operate electrically or magnetically such as heart pacemaker 3) History of claustrophobia 4) The person who are regarded as inadequate for this study by a responsibility researcher

Design outcomes

Primary

Measure	Time frame
Improvement of BD score 12 weeks after treatment	—

Secondary

Measure	Time frame
Prediction of recurrence at the time of treatment-effect judgment Evaluation of the relationships among BD score, CTC, cell free DNA, quantitative value of conventional imaging technique, and clinical information	—

Countries

Japan

Contacts

Public ContactShigeo Okuda

Keio University, School of Medicine Department of Diagnostic Radiology

okuda@rad.med.keio.ac.jp03-3353-1211

Outcome results